Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance to Provide Scrapie Genotyping in Greece

NEW YORK, Aug. 11 (GenomeWeb News) - Genaissance Pharmaceuticals will provide scrapie genotyping services to Antisel A. Selidis of Greece, a contractor for the Greek government, Genaissance said today.

 

Under the agreement, Genaissance will be the exclusive genotyping provider for Antisel, which has been awarded a contract by the Hellenic Ministry of Rural Development and Food. The contract derives from a European Union mandate to establish a breeding program in sheep that confers resistance to scrapie.

 

Antisel is Genaissance's distributor in Greece, Bulgaria, and the former Yugoslav Republic of Macedonia.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.